Carmen Betancourt
General Counsel at CIDARA THERAPEUTICS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey Stein | M | 69 | 10 years | |
| Daniel Burgess | M | 62 | 10 years | |
| Shane Ward | M | 49 | 3 years | |
| Theodore Schroeder | M | 69 | 10 years | |
| Chrysa Mineo | F | 59 | 6 years | |
| Bonnie Bassler | M | 61 | 3 years | |
| Leslie Tari | M | 57 | 11 years | |
| Carin Canale-Theakston | F | 50 | 3 years | |
| Preetam Shah | M | 51 | 3 years | |
| Laura A. Navalta | F | - | 7 years | |
| Taylor Sandison | M | 52 | 9 years | |
| Allison Lewis | F | - | 9 years | |
| Nicole Davarpanah | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James Panek | M | 71 |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | 8 years |
| Matthew Onaitis | M | 53 | 2 years | |
| J. Judice | M | 61 | 3 years | |
| David W. Pritchard | M | 69 | 8 years | |
| G. Kirk Raab | M | 88 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
| Brian O'Callaghan | M | 54 |
Sangart, Inc.
 Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | 6 years |
| Willard Dere | M | 70 |
University of California, Davis
| 7 years |
| Thomas DeZAo | M | 66 |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | 3 years |
| David Nagler | M | 71 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| David Renas | M | - |
Sangart, Inc.
Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | 12 years |
| Jessica Oien | F | 53 | 3 years | |
| Paul Daruwala | M | 55 | 8 years | |
| Steven Elms | M | 60 | 1 years | |
| Timothy Franson | M | 72 | 9 years | |
| David Gollaher | M | 74 | 6 years | |
| Vishva Dixit | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
| Patrick Heron | M | 53 | 1 years | |
| Lawrence E. Green | M | - |
University of California, Davis
| 7 years |
| Robert Perez | M | 59 | 3 years | |
| Scott Rocklage | M | 69 | 6 years | |
| Stephen Peter McCarthy | M | - |
Golden Gate University
University of California, Davis
| 6 years |
| Frank Valone | M | 74 | 1 years | |
| Arthur Levinson | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 19 years |
| Nina Kjellson | F | 49 | 1 years | |
| Elías Fereres Castiel | M | - |
University of California, Davis
| 4 years |
| Jefri Darmadi | M | 64 |
Golden Gate University
| 5 years |
| Dedi Setiadi | M | 57 |
Golden Gate University
| 2 years |
| Suria Martara Tjahaja | M | 59 |
Golden Gate University
| 2 years |
| Edgar Estonina | M | - |
Golden Gate University
| 4 years |
| Mad Yanto Purbo | M | 66 |
Golden Gate University
| 2 years |
| Stephen Minutoli | M | - |
Golden Gate University
| 4 years |
| Darmawan Layanto | M | 55 |
Golden Gate University
| 4 years |
| Adrian Erlangga Sjamsul | M | 59 |
Golden Gate University
| 2 years |
| Perry Pugno | M | - |
University of California, Davis
| 3 years |
| Basil Nundwe | M | - |
Golden Gate University
| 2 years |
| Van A. Tengberg | M | - |
University of California, Davis
| 4 years |
| W. Needham | M | 71 |
University of California, Davis
| 3 years |
| Shehab Nabil Abdul Gafour El-Orabi | M | - |
Golden Gate University
| 4 years |
| Jason Lee | M | - |
Golden Gate University
| 4 years |
| David Berman | M | - |
University of California, Davis
| 7 years |
| Timothy Siddik | M | 62 |
University of California, Davis
| 4 years |
| Mohammad Zaky bin Othman | M | 68 |
Golden Gate University
| 1 years |
| Ann M. Blessing | F | - |
Golden Gate University
| 3 years |
| Achmad Suherman Kartasasmita | M | 64 |
Golden Gate University
| 2 years |
| Woon Yuk Wong | F | 54 |
Golden Gate University
| 4 years |
| Craig C. Ziegler | M | - |
Golden Gate University
| 2 years |
| Kiyoshi Moriya | M | 60 |
Golden Gate University
| 2 years |
| David Hite | M | - |
Golden Gate University
| 2 years |
| Dono Boestami | M | - |
Golden Gate University
| 1 years |
| David Baker | M | 56 |
Golden Gate University
| 3 years |
| Handjojo Rustanto | M | 60 |
Golden Gate University
| 1 years |
| Paul Moller | M | 85 |
University of California, Davis
| 12 years |
| Herman Zhao | M | - |
Golden Gate University
| 2 years |
| Cahyono Halim | M | - |
Golden Gate University
| 2 years |
| Michael Gromis | M | - |
University of California, Davis
| 3 years |
| David Ebersman | M | 54 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 15 years |
| David N. Baker | M | 55 |
Golden Gate University
| 3 years |
| John Burkart | M | 60 |
Golden Gate University
| 2 years |
| Mark Perry | M | 68 |
University of California, Davis
| 3 years |
| Paul A. Sallaberry | M | 68 |
University of California, Davis
| 3 years |
| Elisha Finney | F | 62 |
Golden Gate University
| 2 years |
| Jeffrey Glynn Tarrant | M | 68 |
University of California, Davis
| 4 years |
| Thomas Kabrick Porta | M | - |
Golden Gate University
| 3 years |
| John F. Maroney | M | - |
University of California, Davis
| 4 years |
| Jeffrey G. Katz | M | 67 |
University of California, Davis
| 4 years |
| David Mitchell William Harvey | M | 66 |
University of California, Davis
| 4 years |
| Diane Irvine | M | 65 |
Golden Gate University
| 3 years |
| Sachio Okamura | M | 73 |
University of California, Davis
| 4 years |
| Dana L. Boutain | F | 59 |
Golden Gate University
| 1 years |
| A. Christine Davis | F | - |
Golden Gate University
| 4 years |
| Brian Lillie | M | 59 |
Golden Gate University
| 4 years |
| James C. Wright | M | - |
Golden Gate University
| 1 years |
| Michael Steven | M | 59 |
Golden Gate University
| 2 years |
| Christopher Piety | M | - |
Golden Gate University
| 3 years |
| Carla Tarazi | F | - |
Golden Gate University
| 3 years |
| Greg Friedman | M | - |
Golden Gate University
| 2 years |
| Scott C. Kline | M | - |
Golden Gate University
| 3 years |
| Tammy L. Cyphert | F | - |
Golden Gate University
| 4 years |
| Robert Todd Joyce | M | 66 |
Golden Gate University
| 1 years |
| Stephen D. Cooke | M | - |
University of California, Davis
| 4 years |
| Mohammad Syahrial | M | 58 |
Golden Gate University
| 2 years |
| Jeff P. Coon | M | 61 |
Golden Gate University
| 4 years |
| Chow Boon Tan | M | 65 |
Golden Gate University
| 2 years |
| Randy J. McBeath | M | - |
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | 2 years |
| Joe Markee | M | 70 |
University of California, Davis
| 5 years |
| Robin Praeger | M | - |
Golden Gate University
| 4 years |
| Rudianto Darmawan Santoso | M | 57 |
Golden Gate University
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Carmen Betancourt
- Personal Network
